Interference of a mammalian circRNA regulates lipid metabolism reprogramming by targeting miR-24-3p/Igf2/PI3K-AKT-mTOR and Igf2bp2/Ucp1 axis

被引:0
|
作者
Jiahao Shao
Meigui Wang
Anjing Zhang
Zheliang Liu
Genglong Jiang
Tao Tang
Jie Wang
Xianbo Jia
Songjia Lai
机构
[1] Sichuan Agricultural University,College of Animal Science and Technology
来源
关键词
Adipogenesis; Lipid metabolism reprogramming; Obesity;
D O I
暂无
中图分类号
学科分类号
摘要
White adipose tissue (WAT) is important for regulating the whole systemic energy homeostasis. Excessive WAT accumulation further contributes to the development of obesity and obesity-related illnesses. More detailed mechanisms for WAT lipid metabolism reprogramming, however, are still elusive. Here, we report the abnormally high expression of a circular RNA (circRNA) mmu_circ_0001874 in the WAT and liver of mice with obesity. mmu_circ_0001874 interference achieved using a specific adeno-associated virus infects target tissues, down-regulating lipid accumulation in the obesity mice WAT, and liver tissues. Mechanistically, miR-24-3p directly interacts with the lipid metabolism effect of mmu_circ_0001874 and participates in adipogenesis and lipid accumulation by targeting Igf2/PI3K-AKT-mTOR axis. Moreover, mmu_circ_0001874 binds to Igf2bp2 to interact with Ucp1, up-regulating Ucp1 translation and increasing thermogenesis to decrease lipid accumulation. In conclusion, our data highlight a physiological role for circRNA in lipid metabolism reprogramming and suggest mmu_circ_0001874/miR-24-3p/Igf2/PI3K-AKT-mTOR and mmu_circ_0001874/Igf2bp2/Ucp1 axis may represent a potential mechanism for controlling lipid accumulation in obesity.
引用
收藏
相关论文
共 50 条
  • [41] POU2F2 regulates glycolytic reprogramming and glioblastoma progression via PDPK1-dependent activation of PI3K/AKT/mTOR pathway
    Rui Yang
    Mei Wang
    Guanghui Zhang
    Yanping Li
    Lulin Wang
    Hongjuan Cui
    Cell Death & Disease, 12
  • [42] POU2F2 regulates glycolytic reprogramming and glioblastoma progression via PDPK1-dependent activation of PI3K/AKT/mTOR pathway
    Yang, Rui
    Wang, Mei
    Zhang, Guanghui
    Li, Yanping
    Wang, Lulin
    Cui, Hongjuan
    CELL DEATH & DISEASE, 2021, 12 (05)
  • [43] The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway
    Jie Wang
    Canhua Jiang
    Ning Li
    Fei Wang
    Ying Xu
    Zhengzhong Shen
    Lina Yang
    Zaiye Li
    Caiyun He
    Cell Death & Disease, 11
  • [44] miR-615-5p通过IGF2/PI3K/AKT信号通路调控胃腺癌发生发展的作用机制附视频
    王雪君
    王亚东
    王慧敏
    步雪峰
    医学研究生学报, 2022, (01) : 23 - 29
  • [45] The circEPSTI1/mir-942-5p/LTBP2 axis regulates the progression of OSCC in the background of OSF via EMT and the PI3K/Akt/mTOR pathway
    Wang, Jie
    Jiang, Canhua
    Li, Ning
    Wang, Fei
    Xu, Ying
    Shen, Zhengzhong
    Yang, Lina
    Li, Zaiye
    He, Caiyun
    CELL DEATH & DISEASE, 2020, 11 (08)
  • [46] LncRNA SBF2 Antisense RNA 1 Accelerates the Progression of Colon Cancer via PI3K/Akt/mTOR Signaling Pathway by Targeting miR-506-3p/ZEB1 Axis
    Yang, Fei
    Tao, Min
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2023, 19 (11) : 1896 - 1911
  • [47] miR-885-5p inhibits proliferation and metastasis by targeting IGF2BP1 and GALNT3 in human intrahepatic cholangiocarcinoma
    Sun Lixin
    Sun Wei
    Song Haibin
    Lang Qingfu
    Pei Tiemin
    MOLECULAR CARCINOGENESIS, 2020, 59 (12) : 1371 - 1381
  • [48] MiR-197-3p regulates endothelial cell proliferation and migration by targeting IGF1R and BCL2 in Kawasaki disease
    Li, Yan
    Wu, Xindan
    Gao, Fang
    Wang, Xianmin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (11): : 4181 - 4192
  • [49] LncRNA LINC00689 Promotes the Tumorigenesis of Glioma via Mediation of miR-526b-3p/IGF2BP1 Axis
    Wen-Liang Zhan
    Ning Gao
    Guo-Long Tu
    Hong Tang
    Ling Gao
    Ying Xia
    NeuroMolecular Medicine, 2021, 23 : 383 - 394
  • [50] LncRNA LINC00689 Promotes the Tumorigenesis of Glioma via Mediation of miR-526b-3p/IGF2BP1 Axis
    Zhan, Wen-Liang
    Gao, Ning
    Tu, Guo-Long
    Tang, Hong
    Gao, Ling
    Xia, Ying
    NEUROMOLECULAR MEDICINE, 2021, 23 (03) : 383 - 394